4147.TWO
Price:
$62.8
Market Cap:
$17.16B
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase III clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which completed Phase I clinical trials for treating HIV infec...[Read more]
Industry
Biotechnology
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
4147.TWO
According to TaiMed Biologics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.84. This represents a change of -18.56% compared to the average of 23.13 of the last 4 quarters.
The mean historical Current Ratio of TaiMed Biologics Inc. over the last ten years is 35.31. The current 18.84 Current Ratio has changed 5.23% with respect to the historical average. Over the past ten years (40 quarters), 4147.TWO's Current Ratio was at its highest in in the September 2016 quarter at 269.52. The Current Ratio was at its lowest in in the March 2020 quarter at 3.36.
Average
35.31
Median
10.52
Minimum
5.74
Maximum
171.81
Discovering the peaks and valleys of TaiMed Biologics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 465.45%
Maximum Annual Current Ratio = 171.81
Minimum Annual Increase = -71.23%
Minimum Annual Current Ratio = 5.74
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 25.18 | 322.75% |
| 2023 | 5.96 | -9.24% |
| 2022 | 6.56 | -36.73% |
| 2021 | 10.37 | 72.35% |
| 2020 | 6.02 | 4.87% |
| 2019 | 5.74 | -46.24% |
| 2018 | 10.68 | -71.23% |
| 2017 | 37.11 | -49.62% |
| 2016 | 73.67 | -57.12% |
| 2015 | 171.81 | 465.45% |
The current Current Ratio of TaiMed Biologics Inc. (4147.TWO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
12.57
5-year avg
10.82
10-year avg
35.31
TaiMed Biologics Inc.’s Current Ratio is greater than EirGenix Inc. (7.56), greater than Pell Bio-Med Technology Co., Ltd. (3.49), greater than Sunmax Biotechnology Co., Ltd. (3.85), greater than Medigen Vaccine Biologics Corporation (14.12), greater than Tanvex BioPharma, Inc. (2.97), less than Lin BioScience, Inc. (41.18), less than Handa Pharmaceuticals, Inc. (32.44), less than Caliway Biopharmaceuticals Co., Ltd. (114.40), greater than TTY Biopharm Company Limited (1.77), greater than Ever Supreme Bio Technology Co., Ltd (1.69),
| Company | Current Ratio | Market cap |
|---|---|---|
| 7.56 | $19.21B | |
| 3.49 | $21.09B | |
| 3.85 | $21.24B | |
| 14.12 | $12.34B | |
| 2.97 | $16.05B | |
| 41.18 | $33.67B | |
| 32.44 | $15.56B | |
| 114.40 | $24.55B | |
| 1.77 | $20.89B | |
| 1.69 | $14.37B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiMed Biologics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TaiMed Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is TaiMed Biologics Inc.'s Current Ratio?
How is the Current Ratio calculated for TaiMed Biologics Inc. (4147.TWO)?
What is the highest Current Ratio for TaiMed Biologics Inc. (4147.TWO)?
What is the 3-year average Current Ratio for TaiMed Biologics Inc. (4147.TWO)?
What is the 5-year average Current Ratio for TaiMed Biologics Inc. (4147.TWO)?
How does the current Current Ratio for TaiMed Biologics Inc. (4147.TWO) compare to its historical average?